Both in Biotechnology
aTyr Pharma vs Estrella Immunopharma
Over the past year ATYR returned −81.3% and ESLA returned −80.6%; their daily moves had a correlation of 0.01.
ATYR −81.3% ESLA −80.6%Growth of $1, one year, split-adjusted
| Metric | ATYR | ESLA |
|---|---|---|
| Price | $6.18 | $0.4435 |
| Market cap | $15.4M | $19.3M |
| Today | −6.79% | +6.10% |
| 1 month | −45.5% | +3.4% |
| 6 months | −85.1% | −65.9% |
| Year to date | −80.3% | −71.6% |
| 1 year | −82.5% | −85.5% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | 81.3× | — |
| Net cash | $56.9M | $146.7K |
| Dividend yield | — | — |
| Volatility (60d) | 1,072.3% | 201.6% |
| Short % of float | 10.5% | 4.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).